Connect with us

Media

Latest News

Business Standard Coverage – RMS receives DCGI nod for cell therapy product 13 April 2017 The Mumbai-based Regenerative Medical Services Regrow® (RMS Regrow) has received market authorisation for India’s first cell therapy product, Chondron® ACI, from Drug Read More →

Live Mint – DCGI approves RMS’s cell therapy for cartilage defects 12 April 2017 Regenerative Medical Services Pvt. Ltd on Wednesday said that the Drug Controller General of India (DCGI) recently approved its stem cell-based therapy to treat cartilage defects. Read More →

Pharmabiz – Regrow receives DCGI approval to market Chondron® ACI 13 April 2017 RMS Regrow® has received market authorization for first cell therapy product Chondron® ACI from the ministry of health, India and DCGI. Read More →

Deccan Chronicle Article – It is possible to regrow cartilage and avoid replacement surgeries 18 Apr, 2017 The procedure starts with 100-200 mg of cartilage being drawn from the patient. Read More →

Hindu Business Line Artcile – RMS Regrow® of offer cartilage therapy using own cells 13 April 2017 If you, or any of your family members, suffer from painful joints, and have been recommended surgery, here’s some good news. A new therapy could help you continue Read More →

eHealth – RMS Regrow gets FDA India nod for cell therapy product 12 Apr, 2017 RMS Regrow gets FDA India nod for cell therapy product

Read More →

CNBC Awaz – RMS Regrow’s Mr. Satyen Sanghavi on 1st Cartilage Cell Therapy in India 17 Apr, 2017 Mr. Satyen Sanghavi on Cartilage Cell Therapy in India | RMS Regrow Read More →

Awards

Bone Cell Therapy

Cartilage Cell Therapy

GMP GLP

ISO 13485:2003